Advertisement China Biologic begins operations at new facility in China - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China Biologic begins operations at new facility in China

China Biologic Products has commenced operations at its newly-constructed plasma collection station in Qi He County, Shandong Province, China.

The new facility replaces China Biologic Products’s existing plasma collection station in Qi He County, which had a capacity to collect 60 to 80 metric tons of plasma per year.

As a result of the historic performance at this station, the company decided to expand and renovate the station to create a more hygienic environment with greater collection capacity and to ensure a high quality and quantity of human plasma supply. The company has invested $2 million in the new construction.

Chao Ming, CEO of China Biologic, said: “We are pleased with the commencement of operations at the new Qi He Station. We expect that as the station becomes fully operational, its capacity will increase to the collection of approximately 100 metric tons of plasma supply per year.”